James A. Boiani, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Law360, in “Psychedelic Meds Are Opening a New Frontier for Legal Work,” by Hannah Albarazi. (Read the full version – subscription required.)

Following is an excerpt:

A new wave of experiments with psychedelic drugs is revealing their potential to treat afflictions including depression, addiction and post-traumatic stress disorder, a development that's gradually removing the drugs' stigma and encouraging lawyers to help usher a possible new competitor into the $1 trillion-plus global pharmaceutical market.

With the federal government fast-tracking experimental studies of psychedelic drug-assisted therapies, there's a mad dash to get them through federally authorized clinical trials, nab U.S. Food and Drug Administration approval and get the therapies out to market.

Prestigious universities are joining in, opening research centers, while investors are pumping money into startups and a growing number of psychedelics-related U.S. patents are being granted. Amid this, pioneering lawyers are starting to navigate the uncharted waters of psychedelic law.

Among them is James A. Boiani, an attorney at Epstein Becker & Green PC who advises on FDA compliance. He told Law360 that he sees a "growing recognition of the promise these drugs might hold, ... something that may have been, unfortunately, delayed by stereotypes and history."

Boiani said he isn't expecting widespread deregulation of psychedelics anytime soon, "but," he added, "I'd never say never. People were saying never for pot 20 years ago, and look where we are today." ...

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.